Podcasts about Drug

Dave Rubin of "The Rubin Report" talks to Senator John Kennedy about the real world results of Trump's attacks on Venezuelan drug boats that Democrats would like to ignore; Congress racing to pass key legislation like the National Defense Authorization Act; how one GOP holdout could stall progress; why Republicans need to focus on lowering the cost of living through deregulation and economic reform ahead of the midterms; how a Democratic House could trigger impeachment chaos and gridlock; what makes Louisiana so unique; and much more. Check out the NEW RUBIN REPORT MERCH here: https://daverubin.store/ ----------  Today's Sponsors: Balance of Nature - Make sure you are getting all the positive effects from a wide variety of fruits and vegetables. Get 50% off the Whole Health System FOR LIFE with this limited-time offer! Go to https://www.BalanceofNature.com MASA Chips - MASA's chips contain just three ingredients: organic nixtamalized corn, sea salt, and 100% grass-fed beef tallow. That's it. No seed oils, no mystery chemicals, just real food. Ready to give MASA or Vandy a try? Get 25% off your first order. Go to http://masachips.com/RUBIN and use code RUBIN.  

White House and Democratic lawmakers weigh in on President Donald Trump's Wednesday night primetime TV year-end address, during which the president highlighted what he sees as his achievements after almost a year in office; Democrats make a last-ditch effort to get a vote to extend expiring Affordable Care Act health insurance premium subsidies; Health & Human Services Secretary Robert F. Kennedy, Jr. announces new rules that aim to prohibit gender-affirming care for transgender youth; President Trump signs an Executive Order to reclassify marijuana as a less dangerous drug, to ease restrictions and allow for more research. We will talk about it with Axios reporter Herb Scribner (30); White House says the Kennedy Center for the Performing Arts has been renamed by the board of trustees the Trump-Kennedy Center, but there are questions about whether it would take an act of Congress; House votes to require the gray wolf be removed from the Endangered Species Act list; Pope Leo XIV names a new Catholic Archbishop of New York, who is from Chicago, like the pope. Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 1982, Jack and Miles are joined by host of Go Home Bible, You're Drunk and White Homework, Tori Williams Douglass, to discuss… Vivek Ramaswamy - The Boy Who Thought The Racists Would Accept Him…, Trump Plays WMD Card In War On “Drugs", Okay...The Grinch Is Officially Ruined and More! Vivek Ramaswamy goes to a Turning Point USA event in Ohio and quickly finds out that he is not on the team. What Is an American? Trump declares fentanyl a 'weapon of mass destruction' with executive order The US is already at war with Venezuela Jon Stewart Likens U.S. Aggression Toward Venezuela To Iraq In The 2000s: “Saddest Part … Is That Dick Cheney Won’t Be Around To See It” U.S. Overdose Deaths Decrease Almost 27% in 2024 What’s behind the significant drop in opioid overdose deaths CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths Exclusive: Trump team withholds $140 million budgeted for fentanyl fight Trump Administration Proposes Defunding Federal Narcan Distribution Program Trump administration praised ‘life-saving’ naloxone, then proposed cuts Trump Signs Law to Unlock Billions for Drug Addiction Recovery Charted: Shifts in America's leading causes of death Trump administration shuts down LGBTQ youth suicide hotline NIH Funding Cuts Disrupt Clinical Trials, Affecting 74,000 Participants White House uses 'Grinch' poster and quote to criticize Democrats on healthcare policies Trump’s Education Goon Releases Ultra-Cringe ‘Christmas’ Video How Dr. Seuss Gave Us One of the Most Complex, Socially Important Heist Stories Ever Walmart Serves Walton Goggins as The Grinch To Warm Up Black Friday Welcome to the Grinchʼs Walmart The Grinch is more popular than ever. There's a new McDonald's meal and tons of Christmas merch. Here's why it happened. Why the 'dank, eerie, weird' Grinch movie became a millennial Christmas classic How How the Grinch Stole Christmas Stole Christmas LISTEN: Wandering by Oscar PetersonSee omnystudio.com/listener for privacy information.

If you've got a penicillin allergy, this episode is crucial for you! That's because you can outgrow a drug allergy like this even if you developed it as an adult. Antibiotic allergies are either misdiagnosed or fade over time. Even if you avoid taking antibiotics like the plague, having a drug allergy on your medical chart can end up limiting treatment options if you find yourself truly needing them.In this episode, my guest, Dr. Mariana Castells, breaks down how drug allergies are diagnosed, how long they take to disappear, why they can appear later in life, and how “drug delabeling” could dramatically improve your care (especially when something serious happens). Dr. Mariana Castells, M.D., Ph.D., is a world-renowned expert in allergy and immunology with over 30 years of experience. Whether you have an antibiotic allergy (or you know someone who does), this is a must-listen interview!⭐️Mentioned in This Episode:- See all the references

In February 2025, Kristin and James Brock were found shot to death in their bed in Carroll County, Georgia. Their five-year-old daughter discovered the bodies. Their teenage daughter, Sarah Grace Patrick, called 911. For months, Sarah posted tearful TikToks mourning her parents, gave an emotional eulogy at their funeral, and reached out to true crime influencers asking them to cover the case. She commented on videos speculating about who the killer might be. She allegedly wrote that the media coverage "would be a really big hit." Then investigators arrested her for both murders. Sarah Grace Patrick was sixteen when her mother and stepfather were killed. She's now seventeen, charged as an adult with two counts of murder, two counts of malice murder, and multiple weapons charges. She's being held without bond in the Carroll County Jail, awaiting trial set for January 2026. But this case goes deeper than a teenager's social media activity. Years before the killings, Sarah was caught in a bitter custody battle between her biological parents. At eleven years old, she told police she felt unsafe in her mother's home and begged a court to let her live with her father. Drug allegations. A dropped assault accusation. A blended family with a complicated history. Now the community is divided. Supporters wearing "I Stand with Sarah" shirts packed the courtroom at her bond hearing. The victims' family begged the judge to keep her locked up, fearing for their own safety. Her grandfather insists she's innocent. Investigators say they have "mountains of evidence." No motive has been disclosed. The murder weapon was never found. And the youngest victim in this case — the six-year-old who found her parents' bodies — may have to testify against her own sister. #SarahGracePatrick #TrueCrime #CarrollCounty #KristinBrock #JamesBrock #GeorgiaCrime #TikTokMurder #CourtTV #MurderTrial #JusticeForKristinAndJames Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

In February 2025, Kristin and James Brock were found shot to death in their bed in Carroll County, Georgia. Their five-year-old daughter discovered the bodies. Their teenage daughter, Sarah Grace Patrick, called 911. For months, Sarah posted tearful TikToks mourning her parents, gave an emotional eulogy at their funeral, and reached out to true crime influencers asking them to cover the case. She commented on videos speculating about who the killer might be. She allegedly wrote that the media coverage "would be a really big hit." Then investigators arrested her for both murders. Sarah Grace Patrick was sixteen when her mother and stepfather were killed. She's now seventeen, charged as an adult with two counts of murder, two counts of malice murder, and multiple weapons charges. She's being held without bond in the Carroll County Jail, awaiting trial set for January 2026. But this case goes deeper than a teenager's social media activity. Years before the killings, Sarah was caught in a bitter custody battle between her biological parents. At eleven years old, she told police she felt unsafe in her mother's home and begged a court to let her live with her father. Drug allegations. A dropped assault accusation. A blended family with a complicated history. Now the community is divided. Supporters wearing "I Stand with Sarah" shirts packed the courtroom at her bond hearing. The victims' family begged the judge to keep her locked up, fearing for their own safety. Her grandfather insists she's innocent. Investigators say they have "mountains of evidence." No motive has been disclosed. The murder weapon was never found. And the youngest victim in this case — the six-year-old who found her parents' bodies — may have to testify against her own sister. #SarahGracePatrick #TrueCrime #CarrollCounty #KristinBrock #JamesBrock #GeorgiaCrime #TikTokMurder #CourtTV #MurderTrial #JusticeForKristinAndJames Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

War Room Brown University Shooting May Be Linked To MIT Professor's Murder, Dems Release More Epstein Photos & Trump Downgrades Marijuana Drug Classification

That speech wasn't just good — it was strategic. Tara breaks down why Donald Trump's tightly focused, 18-minute address may be one of the most important speeches heading into the midterms. From crushing prescription drug prices to exposing massive health care fraud tied to Obamacare, insurance companies, and illegal immigration, Trump finally said out loud what most Americans never hear — because if you don't listen to talk radio, you have no idea what was done to this country. This episode explains the corruption, the incentives, and why repeating this message every single day could change everything.

"70 million Americans have criminal records." Connect With Our SponsorsGreyFinch - https://greyfinch.com/jillallen/A-Dec - https://www.a-dec.com/orthodonticsSmileSuite - https://getsmilesuite.com/ Summary In this conversation, Jill Allen and David Harris discuss the critical aspects of hiring practices in orthodontic practices, focusing on how to prevent embezzlement and ensure a safe working environment. They delve into the importance of pre-employment screening, criminal background checks, drug testing, and social media scrutiny. The discussion also covers the significance of dividing duties among team members to mitigate risks, the challenges posed by electronic payments, and the necessity of financial oversight. David emphasizes the need for practice owners to be proactive in safeguarding their practices against potential fraud and to maintain clear communication with their teams. Connect With Our Guest Prosperident - https://www.prosperident.com/ Takeaways Hiring practices should focus on preventing the wrong hires.70 million Americans have criminal records, making background checks essential.Drug testing is becoming easier and should be a standard practice.Social media can reveal a lot about a candidate's character.Dividing duties among team members can significantly reduce embezzlement risk.Electronic payments are easier to divert than physical payments.Regularly reconcile collections with bank deposits to catch discrepancies.Practice owners should print their own financial reports for accuracy.Discrepancies should be investigated through documentation, not just staff explanations.Chapters 00:00 Introduction01:47 Reintroducing David Harris and His Work03:00 The Importance of Hiring Right04:41 Pre-Employment Screening Essentials05:20 Criminal Records and Background Checks07:36 Talking to Former Employers09:05 Drug Testing and Social Media Checks13:41 Legal Considerations in Hiring18:57 Dividing Duties to Prevent Embezzlement26:47 Digital Payments and Fraud Risks28:32 Preventing Employee Theft31:16 Reconciling Payments and Deposits34:44 Ensuring Financial Integrity41:39 Final Thoughts and Contact InformationEpisode Credits:  Hosted by Jill AllenProduced by Jordann KillionAudio Engineering by Garrett LuceroAre you ready to start a practice of your own? Do you need a fresh set of eyes or some advice in your existing practice?Reach out to me- www.practiceresults.com.    If you like what we are doing here on Hey Docs! and want to hear more of this awesome content, give us a 5-star Rating on your preferred listening platform and subscribe to our show so you never miss an episode.    New episodes drop every Thursday!   

Ad Free Dopey:www.patreon.com/dopeypodcastIn this crucial emergency episode, Dave is joined by longtime friend and recovery legend Bob Forrest to process the shock, grief, and fallout surrounding the Nick Reiner tragedy and the public backlash aimed at Dopey.Bob speaks from decades of experience in addiction treatment, psychiatry-adjacent crisis work, and firsthand encounters with drug-induced psychosis, violence, and untreated mental illness. He explains why modern drugs—especially meth and stimulants—are producing homicidal and suicidal behavior, and why families often have no remaining safety net when things spiral.They discuss:Why parents can love their children and still need boundaries, charges, or interventionHow decriminalization + lack of psychiatric resources leaves families helplessWhy people project their own trauma and rage onto public figures and podcastsThe danger of separating “mental health” from active addictionCelebrity kids, resentment, identity, and why some survive while others don'tWhy Dopey is being scapegoated—and why that logic doesn't hold upThe conversation moves through music, recovery, punk rock, famous addiction stories, Christmas memories, suicidal ideation, parenting, and connection, ultimately landing on Bob's central belief: connection, love, truth, and honesty are what keep people alive.The episode ends with Bob defending Dopey's right to tell the whole truth about addiction—ugly, funny, painful, and real—and offering a blunt but heartfelt holiday message to Dopey Nation. All that and more on this brand new Wednesday episode of the good old Dopey show.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Jim and Greg for the Wednesday 3 Martini Lunch as they unpack Sen. John Fetterman's clarification on U.S. strikes against Venezuelan drug boats, wince at House Republicans helping Democrats push an Obamacare subsidy extension, and vent over the deeply troubling conduct of police and politicians in the Brown University shooting investigation.First, they respond to Sen. Fetterman's explanation that U.S. intelligence on the Venezuelan drug boats is clear and comprehensive, with American officials knowing exactly who and what is on board. Jim argues that President Trump's national security team should declassify as much of this information as possible so the public can hear the facts directly.Next, they groan as four House Republicans sign a discharge petition forcing a vote on the Democrats' Obamacare subsidy extension bill. If it passes, pressure will immediately shift to Senate Republicans to follow suit. Jim questions what the point of the shutdown fight was if this is the inevitable outcome, while Greg asks why Republicans in competitive districts can't offer a stronger alternative instead of aligning with Democrats.Finally, they react to the latest, deeply unreassuring statements from officials overseeing the Brown University shooting investigation. Authorities refuse to say what students told them the shooter said before opening fire and are openly scolding reporters for asking questions they don't like.Please visit our great sponsors:Try Quo for free at https://Quo.com/3ML and keep your existing number—Quo means no missed calls, no missed customers.Give your liver the support it deserves with Dose Daily.  Save 35% on your first month when you subscribe at https://DoseDaily.co/3ML or enter code 3ML at checkout. Stop putting off those doctors' appointments and go to https://ZocDoc.com/3ML to find and instantly book a top-rated doctor today.New episodes every weekday. 

Andy starts with Jayden Daniels' first comments since being shut down for the season. (17:45) Is Phil Rivers inspiring other alte kaker QBs to come out of retirement? (34:50) More from around the NFL, including Joe Burrow's mid career crisis in Cincy. To hear the whole show, tune in live from 9:00 AM - 11:00 AM Monday-Friday. For more sports coverage, download the ESPN630 AM app, visit https://www.sportscapitoldc.com. To join the conversation, check us out on twitter @ESPN630DC and @andypollin1See omnystudio.com/listener for privacy information.

TOPICS: Nick Reiner Arrested US Strikes 3 Drug Boats DC Chief Pamela Smith Coffee Talk with David Eon (LIVE WEEKDAY DAILY NEWS TALK) for Tuesday, December 16th, 2025

Drug smugglers are now using cows as a means to transport cocaine and bring drugs into Europe from Latin America. This method is being favoured by cartels knowing that International law enforcement agencies will be reluctant to search cattle ships…Max Stephens, International Crime Correspondent for the Daily Telegraph has been investigating this, and joins Seán to discuss.

After a closed-door meeting, Secretaries Marco Rubio and Pete Hegseth step up for a press briefing on one of the most urgent national security threats right now: drug-running boats coming out of Venezuela. Pags asks the obvious question — who in their right mind is against stopping illegal drugs from flooding into the country? He also points out an inconvenient truth the media ignores: Obama authorized multiple strikes, and no one batted an eye because a president defending the country used to be considered normal. So why the outrage now? Pags breaks down the stunning reality that Democrats are actually siding with the drug runners, and explains exactly what's going on. A sharp, eye-opening hour you cannot miss. Learn more about your ad choices. Visit megaphone.fm/adchoices

Senator Eric Schmitt of Missouri, who serves on the Judiciary Committee and chairs the Subcommittee on the Constitution, joined The Guy Benson Show today to discuss the Trump administration's strikes against drug boats in the Caribbean and Latin America, pushing back on Democratic criticism by explaining why the actions are both legal and necessary. Schmitt also addressed the administration's renewed foreign policy focus on the Western Hemisphere and putting America first, targeting drug cartels and the opioid crisis at home, along with the bipartisan congressional briefings held to share intelligence and details surrounding the strikes. Senator Schmitt then weighed in on the importance of appointing and confirming Trump's judicial nominees, and outlined the Republican approach to healthcare reform. Listen to the full interview below! Learn more about your ad choices. Visit podcastchoices.com/adchoices

December 16, 2025Have you had your dose of The Daily MoJo today? Download the APP HERE"Ep 121625: Dead & Gay | The Daily MoJo"Ella Cook's incident raises concerns about campus surveillance and investigations. The conversation also covers Kyle Rittenhouse's marriage and the cultural significance of General Hospital. Drug classification, particularly marijuana's Schedule One status, is examined alongside its health impacts compared to alcohol. A dialogue between a parent and teacher addresses school safety for LGBTQ+ students and immigration issues. The discussion concludes with reflections on societal changes and the complexities of cultural integration.Phil Bell's Morning Update - Kamala is a consequence:  HEREAllThingsTrains.comAll American Talk ShowAllThingsTrainsPhil on X: HEREDan Andros - host of The QuickStart Podcast and Managing Editor at CBN.com - Is on vaca but still showed up to rant!FaithwireCBN NewsYouTubeOur affiliate partners:EMP Shield - Figuring out the odds of a devastating EMP attack on the United States is impossible, but as with any disaster, the chances are NOT ZERO, and could happen any day. This decade has proven that the weird and unexpected is right around the corner. Be prepared - protect your home, vehicle, even your generator - with EMP Shield. You'll save money and protect what's important at the same time!ProtectMyMoJo.com Be prepared! Not scared. Need some Ivermection? Some Hydroxychloroquine? Don't have a doctor who fancies your crazy ideas? We have good news - Dr. Stella Immanuel has teamed up with The Daily MoJo to keep you healthy and happy all year long! Not only can she provide you with those necessary prophylactics, but StellasMoJo.com has plenty of other things to keep you and your body in tip-top shape. Use Promo Code: DailyMoJo to save $$Take care of your body - it's the only one you'll get and it's your temple! We've partnered with Sugar Creek Goods to help you care for yourself in an all-natural way. And in this case, "all natural" doesn't mean it doesn't work! Save 15% on your order with promo code "DailyMojo" at SmellMyMoJo.comCBD is almost everywhere you look these days, so the answer isn't so much where can you get it, it's more about - where can you get the CBD products that actually work!? Certainly, NOT at the gas station! Patriots Relief says it all in the name, and you can save an incredible 40% with the promo code "DailyMojo" at GetMoJoCBD.com!Romika Designs is an awesome American small business that specializes in creating laser-engraved gifts and awards for you, your family, and your employees. Want something special for someone special? Find exactly what you want at MoJoLaserPros.com  There have been a lot of imitators, but there's only OG – American Pride Roasters Coffee. It was first and remains the best roaster of fine coffee beans from around the world. You like coffee? You'll love American Pride – from the heart of the heartland – Des Moines, Iowa. AmericanPrideRoasters.com   Find great deals on American-made products at MoJoMyPillow.com. Mike Lindell – a true patriot in our eyes – puts his money where his mouth (and products) is/are. Find tremendous deals at MoJoMyPillow.com – Promo Code: MoJo50  Life gets messy – sometimes really messy. Be ready for the next mess with survival food and tools from My Patriot Supply. A 25 year shelf life and fantastic variety are just the beginning of the long list of reasons to get your emergency rations at PrepareWithMoJo50.comStay ConnectedWATCH The Daily Mojo LIVE 7-9a CT: www.TheDailyMojo.com Rumble: HEREOr just LISTEN:The Daily MoJo ChannelBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-daily-mojo-with-brad-staggs--3085897/support.

Retatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what this podcast is going to be about today. There's well over a hundred thousand people by my estimates who are already on some form of this medication today. And that should tell you enough about how disruptive this molecule is and will be. It is a game changer among game changer. We've been talking about it for three years here at On The Pen, well before any of your favorite gym bros were talking about Retatrutide. We were talking about Reta, who tried Retatrutide here at On The Pen. And that's because we identified this triple agonist as a game changer among game changers. So This is going to be a very Retatrutide heavy episode, and so I hope you'll join us and stick with us if this is a topic you enjoy, because I think this is really going to effectively lay the groundwork for what accessibility to this medication will look like. So let's get into it. Welcome to the On The Pen Podcast with your host, Dave Knapp. Welcome to the On The Pen, the weekly dose podcast. This is our weekly roundup in incretin memetic news. And frankly, there's no news that is bigger than Reta-Trutide news. Just find me any news that is bigger than the data that we got on Reta-Trutide. Now, we already did a video about the Triumph Phase II clinical trials that we got in osteoarthritis of the knee. You can go back and check out that video if you'd like more data. So we're not gonna super... rehash the data. We'll go over at a high level what the data showed us. We're not going to go over how the medicine works, because by now we all know that it's the triple agonist, right? If terzapatide was a dual agonist, GLP-GIP, Retatrutide is the triple agonist that adds to it a glucagon component, which is absolutely just shredding, shredding liver fat. It is absolutely revving up people's metabolism and showing a tremendous amount of weight loss. So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent. They bumped up to four milligrams. Those folks lost twenty two percent. So right there at the lowest dose, you're already reaching the efficacy of today's drugs that are on the market, like triseptide and semaglutide in their various forms. If you bumped up to eight milligrams, you saw twenty four percent placebo adjusted weight loss and at twelve milligrams, twenty six point four percent weight loss. Adding back in that two percent of the placebo that those on placebo loss, that's twenty eight point four percent weight loss in these forty eight weeks at the highest dose. When you adjust for some of the more real world outcomes, you kind of ding the numbers a little bit based upon people who quit the drug, et cetera. Those numbers look more like a twenty percent weight loss and twenty three point seven percent weight loss at the highest dose. But even then, you're still seeing a drug that is better than the current drugs that are on the market. around forty eight percent of patients on Retatrutide lost greater than twenty five percent. And then if you were at that twelve twelve milligram dose, that highest dose patients lost fifty nine percent of patients lost more than twenty five percent of their body weight. There was a subset that lost thirty percent of their body weight and some even over thirty five percent of their body weight on Retatrutide. So the lower doses compete with today's best drugs and the upper doses are entering into bariatric surgery level weight loss. And that's putting the whole obesity system on notice and probably a lot of surgeons nervous because typical body weight loss was something like the street sleeve gastrectomy. For example, it's about eighteen to twenty five percent body weight. The Roux-en-Y gastric bypass twenty five to thirty five percent weight loss or the duodenal switch thirty to forty percent weight loss. So the upper doses of Ritutrutide overlap with sleeve and bypass outcomes without any surgery. It's incredible. It is a game changer among game changer. It is the new benchmark in obesity medicine. And there's actually more data, like I said, landing in later twenty twenty six. The longer duration will historically, if history is a marker, equal more weight loss than we even see here at this forty eight weeks. We have an interview that will be airing later this week on our channel and on our podcast with our friend Mimi from Australia who just wrapped up her clinical trial on Retatrutide. They ended it like ten weeks early on her, which was a huge bummer to her. So we're going to hear from her because she had to end abruptly. We're going to hear her story, an incredible story. She's one of those folks that got up that thirty five percent body weight loss in the time that she was on Retatrutide. So, this is just showing you that these drugs are not simply an alternative to bariatric surgery. We are approaching a point in time where these are on par with bariatric surgery, and as people are on this Reta-Trutide trial, you see that these numbers aren't plateauing either. So we will see stronger weight loss numbers the longer that these folks are on this trial. And I think you'll see some of those numbers in that population of folks on the higher doses eclipse maybe even some of what we see with some of these bariatric surgeries. the real story that i think is taking shape here is not in how powerful Retatrutide is because we've literally been expecting or anticipating this kind of data for more than three years at on the pin we've been talking about this and i think that's sort of reflected in the fact that you didn't see this massive spike in eli lilly stock wall street was expecting this as well Um, so it was on par, I think with expectations, but the expectations are astronomical compared to previous options that were available to patients and all the innovation in the world. All of these drugs, we talked at last week about WV, E double Oh seven, the James Bond of weight loss that targets fat, not only targets fat loss, but it also targets the promotion of building of, of lean muscle mass. We're talking about an insane future in obesity medicine. But none of it means anything if people can't access it. And that's really where we are today in terms of ensuring that there's going to be an option for everyone. And that's sort of what I want to get into today, because Lilly wants Retatrutide to be classified as a biologic, so not a traditional small molecule drug like you've seen every other incretin and nutrient-stimulated hormone-treating obesity on the market to date. They're trying to get this classified as a biologic. Now, we talked about this before on the podcast. That matters in three major ways. It affects the exclusivity length of time that a pharmaceutical company has on a drug. That goes from, I believe, five years of market exclusivity to twelve. It affects compounding rules because biologics cannot be compounded. And then that gives the pharmaceutical companies a tremendous amount of pricing power in the marketplace, because essentially there's no competition and there's no competition for a long time. But this whole argument about getting this classified as a biologic is not about safety. It's about protection and we're going to get into it. So let's explain this here. This is why Retatrutide really is not a biologic arguably. So biologics are large proteins. There are hundreds of or even thousands of amino acids grown in living cells that are sensitive to tiny manufacturing changes. Retatrutide is a short chain peptide. It's chemically synthesized and it is below the traditional biological size thresholds when it comes to how those things are defined. We'll just leave it at that. So even though it acts like a biologic in the body, it's made like a drug. It's made like a small molecule drug. And if it's treated as a drug, they get, like I said, five years of market exclusivity. Now, really a lot of confusion around what this means, but essentially the first five years of the life of a drug, the patent can be challenged for a number of reasons. We've seen patent challenges right now are going on in the courts for both semaglutide and terzepatide. But these companies are guaranteed that five years of market exclusivity, no matter how those patent lawsuits shake out. That five years jumps to twelve years with the biologic. So ultimately, there's no biosimilars that are allowed during that twelve year window. Again, with terzapatidin and semaglutide, it's five years. They could lose their market exclusivity within five years of the release of the patent. twelve years with a biologic. So if they lose their patent challenges on Trezabitide, they still have some time left with market exclusivity for the drug. They likely will not lose those, but that jumps to twelve years. And I think the most important thing to understand about the reclassification of Reta-Trutide to a biologic would mean that, 503A and 503B pharmacies are effectively locked out of compounding this medication, 503Bs would have some latitude arguably, but they would face extreme barriers. Routine compounding becomes legally and technically restricted because biological status doesn't slow compounding down. It actually shuts the door or almost completely shuts the door. Biologics not only would allow Lilly to have longer market exclusivity, no compounding, but it would allow them to command a higher price in the marketplace because A, they get this designation and there's an assumption when they bring this to market that they're harder to manufacture, that they're harder to copy, that there are fewer negotiating alternatives for payers. They can command a higher price with the insurance companies, and the price pressure stays muted for much longer because, again, you don't have those pressures of compounding. You don't have the pressures externally from lawsuits that could end your market exclusivity in that first five years of the drug's existence. So there's just a lot of price pressure upwards on a biologic compared to a normal small molecule drug. And when there's no credible alternative or backup option, which to Retatrutide, there wouldn't be, it'd be the first drug that has bariatric surgery level results. The prices won't come down. They'll command a massive price and the prices won't come down. So let's talk about where this currently stands because ultimately the Eli Lilly went to the FDA. We've been covering this for well over a year, maybe close to two years now, a year and a half at least. Lily went to the FDA, they said, we want this classified as a biologic, here are the reasons why. The FDA initially said, no, we're not gonna do that. So Lily challenged that decision in court. So the point that we're at today is the court told the FDA to reconsider and better explain itself So the first no given to the FDA to Lilly didn't stick. The courts looked at it and they said, you need a better, you need to reconsider your decision and you need to explain your decision better to Lilly. So ultimately we're sitting now at the point where the court has made its decision that the FDA has to go back and now we await basically what the FDA has to say on this. But if this thing is classified as a biologic, that would be a massive massive loss for patients. Now, again, we're, we're focusing on the accessibility of this drug into the future. And, and I think that this is an important conversation to have. One of the interesting points that I have to bring into the conversation is the fact that I got to sit in on a, on a closed session question and answer with the media. I didn't get to answer or, excuse me, excuse me, ask a question at this time, but shortly after the most favored nations announcement, with eli lilly and the trump administration in the oval office that day there was a press briefing that i was invited to dave ricks was asked by max bayer reporter of endpoints who we've interviewed here on this very podcast and he was asked was Retatrutide included in the most favored nations discussions meaning will we get a cash pay version of Retatrutide uh that is you know circumventing the pbms uh will we get these cheaper prices will will it be be two hundred fifty dollars also and there was a hard no there was a hard no like no that was not included that was not part of these discussions even though what we heard from the trump administration was that those these companies that were jumping on to the most favored nations agreement were also agreeing to offer future drugs at most favored nations pricing now was lily saying that no they're not going to offer it at the it wasn't part of the negotiations in terms of the price points that they had discussed for triseptide maybe or did it mean altogether there won't be a cash pay option of this medication i don't know um that we would love to get clarity on But I highly doubt we're going to get any more information than necessary at this point in time. So, Reta-Trutide is being positioned to be a drug that, and well so, should be offered at a premium. This is a drug that is far exceeding the current drugs that are on the market. I think that we're gonna see even the indications of Reta-Trutide far beyond simple obesity, but it is going to be their crown jewel for the next decade, more than likely. Reta-Trutide is going to be a massive drug, and so they're attempting to build a moat around it. And these are things that we need to be aware of as a community so that we can hold our positions and conversations about these and basically, you know, be able to articulate to people in positions of power like this is an important thing to us. This is an important thing in the advocacy of obesity and sort of the next frontier of the fight of accessibility, which marches on. each and every day because of course the current drugs, while as great as they are and as much as access is expanding, there are still people with sicker or rather more advanced versions of metabolic disease that are gonna need these newer treatments and price is going to be a huge factor. So let's talk about the gray market right now because I think it's also nearly impossible to talk about this topic without including a discussion about the gray market because there are, as I mentioned at the outset, hundreds of thousands of people on this medication already. So research grade Retatrutide exists. It's in the gray markets of the Internet. It's where people are going and they're buying, you know, basically versions of these these peptides that are made in factories overseas. They're being imported into the United States, oftentimes illicitly in shipments that are marked as something else. The FDA has tried to crack down. There's no doctor involved in this. It's a very, that's why it's called the gray market, right? So it's not a prescription medicine, but the demand for this is massive. And all you have to do is really scroll your TikTok for about fifteen minutes. You're going to come across a insane amount of content on the topic of Retatrutide. An insane amount of, and oftentimes, you know, what I find most disturbing is oftentimes it looks like very young people. very young people taking Retatrutide. Crazy, it's crazy. But the demand is massive and there's a whole gray market for it proliferating over on TikTok and in the far reaches of the internet. And I would estimate that tens, if not hundreds of thousands of people are already or have already used it. And I think it's a testament to a to to the effectiveness of this drug. It's also a testament to the fact that there needs to be more guardrails, I think, around this stuff than there currently is, because gray markets appear and they thrive when legal access lags the reality of the demand for the medication. And you saw this earlier this week as we launched a petition to fight back against the Safe Drug Act of twenty twenty five, a drug, a drug act that is in theory designed to put guardrails around compounding. But in practice, I think is creating a new battlefield for Eli Lilly and Novo Nordisk to shut down compounding on the current classes of medications, which is why We as a community need to be loud about our opposition to it. If they were really concerned about the safety of compounds, they would do two very simple things. They would require reporting around the active pharmaceutical ingredient of a compound. Patients ought to be able to know where the actual source of their medication is coming from. And they should know that those places are FDA approved and inspected. And the second thing is they should require adverse event reporting. Those are required of 503Bs. They should be required of 503As as well. 503As are making a tremendous amount of money. They're making thousands and thousands of these scripts. So when there are adverse events, they should be required to report those to the FDA. Simple. None of that is in this bill. None of it. None of it. Instead, it seeks to put caps on the amount of compounds that can be made by a compound pharmacy without them having to report to the FDA. And then it seeks to codify the definition of essential copy. Again, all of these things that will become law and then argued in court and then a battlefield for Lilly to potentially win a legal battle and thwart compounding. It's creating a new battlefield for them. They're losing in the courts. They're losing with the current language that exists in the Food, Drug, and Cosmetic Act. So we create new language. We create new law. Just vague enough to pull some threads and hopefully win something in court. That's how I see it. You may see it differently. If you do, curious to hear from you. But if you want to fight back against this legislation, you can go to otplinks.com and fight back against that. piece of legislation, because I think that we need as a community to have our voices heard on this, especially those who have gotten healthier by way of compounded medications. So the rumor on the gray market, to get back and close the thought loop here, There's been no specific FDA cutoff announced, but what the rumors going around are that that the compounded versions of GLP ones, especially obesity medicine in the gray market, are all going to turn off like a sieve on January first. Now, I seem to feel like this is probably more of a marketing tactic by these companies to sell a whole bunch of peptides at the end of the year. I think that's probably creating some panic and probably panic buying on people's parts. And so these companies are benefiting greatly. Again, that's why there should be guardrails around this. There's no guardrails around this at all. I mean, at the end of the day, they can say whatever they want to say, so long as they cloak everything in research grade. And these rumors proliferate around and people spend thousands, tens of thousands of dollars. I've heard of people having twenty years worth of Retatrutide in their freezer. Why? For what purpose do you need that? So just a massive amount of money made in this gray market. And that's not to knock people who use it. I say this all the time, but I think it's worth qualifying the statement. It's not knocking people who use it. I get it. But at the same time, we're talking about an industry that is, there's no altruism here. They're in it for money just as much as Eli Lilly is, except they have actually done nothing in the way of advancing medicine. They've just taken intellectual property, copied it, and sold it to you with a label that says, don't put this in your body. So you know where I stand on the gray market. I've heard from many people who've been injured by gray market stuff. It's just what it is. It's a gray market. You're taking your health into your own hands. Please, whatever you're doing out there, as risky as it may be, please involve your doctor and let your doctor know what you're doing so you can be monitored for the things your doctor believes you should be monitored for if you're using this. But this all underscores, again, the need for accessibility to these medications, the need for us to be aware of the fact that a moat is already being built around the most advanced metabolic drug in the pipeline. And we just need to be aware so that when it comes time to fight, we're all ready and informed. And that's what this podcast is serving to do. Before we jump into the next topic, I do want to thank our sponsor, our headline sponsor of this podcast. is a company called Shed. Now, if you are looking for access to care for obesity, then look no further than our partners at Shed who believed in this podcast enough to help us do it full time. You can go to Trished.com and use code OTP25 to save twenty five percent at Trished.com, where you're going to get connected to a doctor who will when medically necessary prescribe medication to treat your obesity. You also get access to coaching. You'll get access to all sorts of medication, whether it's the branded or the compounded versions, depending on your specific situation. All of it is available at Trished.com. They use one of my favorite compound pharmacies in the game, Strive Pharmacy, which I've gotten the chance to dig into on my own. I really love what they do there. They're a It functionally operates a lot more like a 503B. Uh, and I think that they're doing great work over at a strive pharmacy. They partner with shed. So I just love this, this, and when we were looking for somebody to offer a compounded versions, I wanted to make sure that I trusted the pharmacy. People always ask me, Dave, who, who should I go to? I'm like the pharmacy matters more than anything because you want to trust the source of your medication. So try shed.com use code OTP25. Listen, you're going to want to learn about taking any new medication before you take it. Learn about the potential side effects. Learn about the trade offs. There's no free lunch, but all of the information that you're going to need, you can find it. Try shed.com and be familiarizing yourself with all of your options there. So thank you to Shed for being a wonderful partner here at On The Pen. Now let's talk about some data that dropped. We're talking about accessibility and all of the sort of advancements in the world mean very little if people can't access it. That's why I think this data that dropped this past week from our friends over at Rowe is incredible. Absolutely game changing data. So check out this data. Real world telehealth data looking at sixty eight weeks. This is looking at patients who were enrolled in their row body program and on a GLP one specifically some maglutide mean weight loss in this study looked at again patients in over sixty eight weeks. The mean weight loss was sixteen point six percent on average. Thirty three percent of patients lost more than twenty percent and the safety in this study and looking at this data match the clinical trials. So what we're seeing here is that care for obesity can be delivered through a telehealth platform at scale and match clinical trial results. So that scalability decides how many people get access. There are not enough doctors out there to serve the over hundred million people in the United States living with overweight or obesity. so when you hear these blowhard doctors online calling all telehealth platforms except their own a pill mill or as i like to say pin mill the data is actually showing something quite different in that this type of obesity care can be delivered at scale through telehealth platforms it can meet people where they're at and allow people to get care without the shame, without the stigma, without their doctor just pointing to the door and saying, if you want a GLP-I, get out of my office. I ain't going to get it here. How ridiculous. But these people can go to platforms like Rho or Shed or any number of telehealth platforms that are out there and not only get access to medicine, but get access to care. So of course, not all telehealth companies are created equal. Of course, not all compound pharmacies are created equal. You want to do your homework and all of that. But this is data that shows that This kind of care can be delivered at scale via a virtual platform and show similar results to a clinical trial. I think, and this is peer reviewed data, and I think that this is just absolutely great news because when we talk about the problem, we need scalable solutions. The old brick and mortar ain't going to work when you don't have enough doctors to serve enough patients. If we want to get life-changing treatments like ritatratide or terzapatide, semaglutide, whatever, into the hands of the people who need it the most, we need companies to innovate scalable tech platforms that can meet patients where they are, that can leverage current technologies to find people the care that they need. And in this case, it's access to a doctor. It's access to a platform. It's access to prescription medication when appropriately prescribed. And it can be done, and it is being done. So I think this is great news, and will play a huge part in the future. As we talk about Retatrutide, even though it's a year and a half away, maybe a little bit longer, it's already exposing – the issues around accessibility and pricing. Hopefully there will be compounded versions available if they're medically necessitated, if there are shortages. We hope that the battleground for that is not already set and won by Lilly before this drug even comes to market. But there are strategies being done to keep people boxed out But I can tell you that whatever happens with Retatrutide, the future of obesity medicine is in virtual care. And platforms are rising to the occasion. Retatrutide hasn't reached patients yet, but it's already forcing the system to show us, you know, are you ready? Are you ready to deliver bariatric surgery level results at scale to the people who need them? So I am so thankful that you joined me here on this podcast today. Again, we love to talk about we're at a Retatrutide. If you're interested, we've been going live every Monday, Wednesday and Friday at eleven a.m. Central Time here on our YouTube channel, on our tick tock, on our X platform. We're doing that because there's enough news to bring you just about every single day. And we've been doing it for the last couple of weeks. If you've enjoyed it, let me know in the comments of the video on YouTube. Send me an email at David on the pen dot com. Uh, so every single Monday, Wednesday, Friday, and then we do a weekly rundown of the obesity medicine news every Tuesday. That's what this is. The weekly dose podcast. You can catch this on all of the platforms that you listen to your podcasts on, and please make sure to leave us a five star rating and review before you log out of your podcast app. That helps so much. I don't think you guys understand how much that helps, uh, the work that we do here to just train the podcast algorithms that this one is worth listening to. I hope you enjoyed today's podcast. If you did, drop it a thumbs up, five-star review, subscribe on YouTube, do all the things. Thank you for being here, and thank you for being the best part of what we do. We will catch you on the next one. Thank you, my friends. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Opinions Matter, Adrian and Jeremy debate giving money to beggars. Triggered by a listener's personal dilemma, the lads tackle uncomfortable questions about addiction, homelessness, and the ethics of charity. Listeners argue both for and against handing cash to those in need. Is giving a few euro a kindness or a dangerous enabler?

In this episode you will hear stories from three diary's. The first is about a woman who explored the Mighty Mississippi River year after year and shared her knowledge by publishing her own guide books. Next, a diary where the author experienced a premonition that sadly came true. Her diary has a gap of almost three years to when she recorded the life altering event. Lastly, we read entries from a drug fueled trip through Mexico in the 1990's. There are several funny quotes, a few weird encounters, and some introspective thoughts written by this young man-- who may have been high when he wrote them!      Send us a textPlease go to: https://diarydiscoveries.com to see episode photos and read our blog. Thank You.

Dr. Dubrow names the GLP-1 that will take over 2026. Meanwhile, Heather takes a ‘jab’ at post-Ozempic beauty standards, and who is Terry telling to STFU?See omnystudio.com/listener for privacy information.

Which is the safest and most effective statin?

Trump's collapsing polls reflect real economic pain—rising costs, health-care sabotage, and elite corruption—exposing why voters no longer trust GOP economic claims.Subscribe to our Newsletter:https://politicsdoneright.com/newsletterPurchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make AmericaUtopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And BeFit Now: https://amzn.to/3xiQK3K Tribulations of anAfro-Latino Caribbean man: https://amzn.to/4c09rbE

Thank you ITS Never Happening…, P. J. Schuster, Steven Rosenzweig, Christiane mccafferty, LBW, and many others for tuning into my live video! Join me for my next live video in the app.* I had coffee with a MAGA and a progressive listener this Sunday: A Politics Done Right supporter who donated to KPFT for a “Coffee with Egberto” invited our most MAGA listener to join us. It was enlightening, frustrating, … To hear more, visit egberto.substack.com

Developing complex biologics and advanced therapies is historically time-consuming and material-intensive—but computational modeling is reshaping the formulation landscape.In this episode of Life Science Solutions, host Chris Adkins is joined by Andrea Arsiccio, PhD, Senior Scientist and Team Lead In Silico at Coriolis Pharma, to discuss how in silico modeling is revolutionizing the assessment of developability and formulation strategies for new drug products.Andrea breaks down how Coriolis Pharma combines physics-based models and Artificial Intelligence with traditional wet lab experimentation to predict molecule behavior, identify liabilities early, and solve complex problems like aggregation and viscosity.Topics Include:Defining In Silico: Understanding the spectrum from mechanistic models and molecular dynamics to AI and machine learning.Accelerating Development: How computational tools reduce the need for animal testing and save precious material in early-phase development.The "Why" Behind the "What": Using modeling to uncover the specific mechanisms causing instability or aggregation.The Hybrid Approach: Validating digital predictions with high-throughput wet lab screening for a robust formulation strategy.Regulatory Perspectives: How the FDA and EMA are viewing AI data and the importance of establishing model credibility.Expansion: Coriolis Pharma's growth into the US market and their new capabilities in Research Triangle Park.Whether you are a formulation scientist, a CMC leader, or a regulatory professional, this episode provides a fascinating look at how digital twins and computational strategies are de-risking the path to market for life-saving therapies.

Shannon Davis, a Registered Dietitian Nutritionist with more than 19 years of experience specializing in metabolic health and insulin resistance. She's a founding board member of the American Diabetes Society, an Insulin IQ Coach, and the founder of a successful virtual metabolic health practice where she's helped nearly a thousand people reverse insulin resistance, lose weight, and even put type 2 diabetes into remission. Shannon's background spans dialysis, organ transplant, bariatrics, and pharmaceutical sales — giving her a unique perspective on why food, not medication, is the real solution to most dietary conditions. She's been featured on over 50 podcasts as an expert in metabolic health, and when she's not helping people transform their lives, you'll find her in the gym doing CrossFit or spending time riding horses — her lifelong passion. Instagram: https://www.instagram.com/sldavis6580 X: https://x.com/fittoeat6580 YouTube: https://youtube.com/@shannondavis1619 Facebook: https://www.facebook.com/shannon.davis.9279 Website: https://shannonfeelgreat.com/ Timestamps: 00:00 Trailer 00:53 Introduction 05:31 Renal care challenges and ethics 09:11 Kidney health and low-carb diets 10:41 Keto and kidney care 13:44 Dialysis conflict of interest 18:39 Diabetes advocacy and carnivore 21:16 Ketogenic diets and diabetes 24:02 Preventing heart disease 28:16 Diet wars and social media 31:26 Better living through medication 34:04 Platform censorship frustrations  37:14 Grassroots health movement challenges 42:51 AI transforming pharmaceutical marketing 43:30 Drug industry priorities  49:16 Low carb diet and cholesterol 50:29 Where to find Shannon 53:43 United in the fight Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

Before anything else, it was binging. Using food to cope, numb out, reward myself, and avoid dealing with what was actually going on.In this episode, I talk about my messed-up relationship with food, how binging showed up early in my life, and how that lack of discipline didn't stay isolated. It spilled into everything.If you've ever said “I'll start Monday,” “I deserve this,” or “it's just food,” this one's probably for you.We talk about gluttony, self-mastery, and why learning to control what you eat has way more to do with freedom and holiness than aesthetics.No meal plans. No nutrition hacks.Just honesty, discipline, and a call to get your house in order.Let's get after it.New Episodes Every Sunday Join The Catholic Warrior Coaching Program Here: ⁠ https://catholicwarrior.comSubscribe to Youtube: ⁠https://www.youtube.com/@catholicwarriorpodcast⁠ Follow us on Instagram: ⁠https://www.instagram.com/catholicwarriorpodcast/?hl=en⁠

Chris Markowski, the Watchdog on Wall Street, discusses various pressing economic issues, including the role of government in economic growth, the impact of tariffs, state governance, immigration, and drug trafficking. He emphasizes the importance of financial freedom and the need for individuals to take charge of their economic futures while critiquing government policies that hinder growth and prosperity.

The crackdown on drug drivers is due to start today. Starting in Wellington first, saliva testing will be used to test the drivers for 4 drugs; cannabis, meth, MDMA and cocaine. Police Minister Mark Mitchell told Heather du Plessis-Allan that the drug tests being used are new to police, and a trial period is necessary before a national rollout. "We will scale it up, but the police have to make sure. It's a new form of testing, so it's important to trial it." LISTEN ABOVESee omnystudio.com/listener for privacy information.

This is a clip from a subscribers-only episode. CLICK HERE TO SUBSCRIBE AND LISTEN. As we continue our exploration of various forms of intoxicants, I share some personal stories and insights about America's favorite mind-altering substance: alcohol. From teenage experiments with wine coolers to the tipsy world of New York City dive bars, I've collected some hard-earned perspectives on the complicated role booze plays in our lives and the wider world. Cheers!

Episode Overview: In our inaugural This Week in Pharmacy, we examine the economic, technological, and policy-driven forces transforming pharmacy practice and the U.S. drug supply chain. From hidden financial power structures and AI-enabled operations to federal policy shifts impacting biosimilars, this episode brings together three timely conversations that every pharmacy leader should hear. Segment 1: The Hidden Lender in America's Drug Supply Chain Guests: Antonio Ciaccia, President, 3 Axis Advisors Alec Ginsberg, Founder, The Drugstore Cowboy Building on Alec Ginsberg's investigative article, “The Hidden Lender in America's Drug Supply Chain,” this discussion exposes how capital flows, credit structures, and opaque financial relationships influence pharmacy viability. Ciaccia and Ginsberg break down what independent pharmacists need to understand about who truly controls leverage in the system—and why transparency matters more than ever.   Segment 2: How AI Is Transforming Pharmacy Operations Guests: Harry Travis, BS Pharm, MBA, President, The Travis Group Amanda Awe, PharmD, Clinical Product Consultant, Curatio Advisors Artificial intelligence is no longer theoretical in pharmacy—it's operational. This segment explores how AI is being deployed today to improve workflow efficiency, clinical decision-making, and patient engagement, while addressing the real-world challenges of adoption. Segment 3: Policy Watch – IRA, Trump-Era Rx Changes & Biosimilars Guest: Jessica Daley, PharmD In this special policy-focused feature, Dr. Daley unpacks upcoming IRA-related developments and potential Trump-era prescription drug policy changes, with a sharp focus on how they could impact biosimilars and the U.S. supply chain. The conversation highlights what pharmacists should watch closely as regulatory and political pressures continue to evolve.   Inside the Forces Reshaping America's Drug Supply Chain | TWIRx    Thanks to NimbleRx, PRISM by OvaryIT, and Sykes & Company for sponsorsing today's show

Segment 1: The Hidden Lender in America's Drug Supply Chain Guests: Antonio Ciaccia, President, 3 Axis Advisors Alec Ginsberg, Founder, The Drugstore Cowboy Building on Alec Ginsberg's investigative article, “The Hidden Lender in America's Drug Supply Chain,” this discussion exposes how capital flows, credit structures, and opaque financial relationships influence pharmacy viability. Ciaccia and Ginsberg break down what independent pharmacists need to understand about who truly controls leverage in the system—and why transparency matters more than ever. Segment 2: How AI Is Transforming Pharmacy Operations Guests: Harry Travis, BS Pharm, MBA, President, The Travis Group Amanda Awe, PharmD, Clinical Product Consultant, Curatio Advisors Artificial intelligence is no longer theoretical in pharmacy—it's operational. This segment explores how AI is being deployed today to improve workflow efficiency, clinical decision-making, and patient engagement, while addressing the real-world challenges of adoption. Inside the Forces Reshaping America's Drug Supply Chain | TWIRx    Thanks to NimbleRx, PRISM by OvaryIT, and Sykes & Company for sponsorsing today's show

- President Donald Trump talks about combatting drugs and migration from Venezuela. - Foreign policy analysts Fred Fleitz and Tim Stewart react to the seizure of a Venezuelan oil tanker. - Carl Higbie calls out Speaker Mike Johnson, urging him to “do what you promised.” - The “Right Squad” panel takes issue with Gavin Newsom's extreme pro-trans stance. Today's podcast is sponsored by : WEBROOT : Live a better digital life with Webroot Total Protection. Newsmax Daily listeners get 75% off at ⁠⁠⁠⁠⁠http://webroot.com/Newsmax⁠⁠⁠⁠⁠  NOBLE GOLD : Open a new qualified IRA or cash account with Noble Gold and get a FREE 10-ounce Silver Flag Bar plus a Silver American Eagle Proof Coin. Visit ⁠⁠⁠⁠http://NobleGoldInvestments.com/Newsmax⁠⁠⁠⁠ Listen to Newsmax LIVE and see our entire podcast lineup at ⁠⁠⁠⁠⁠⁠http://Newsmax.com/Listen⁠⁠⁠⁠⁠⁠ Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at ⁠⁠⁠⁠⁠⁠http://NewsmaxPlus.com⁠⁠⁠⁠⁠⁠ Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : ⁠⁠⁠⁠⁠⁠http://nws.mx/shop⁠⁠⁠⁠⁠⁠ Follow NEWSMAX on Social Media:  -Facebook: ⁠⁠⁠⁠⁠⁠http://nws.mx/FB⁠⁠⁠⁠⁠⁠  -X/Twitter: ⁠⁠⁠⁠⁠⁠http://nws.mx/twitter⁠⁠⁠⁠⁠⁠ -Instagram: ⁠⁠⁠⁠⁠⁠http://nws.mx/IG⁠⁠⁠⁠⁠⁠ -YouTube: ⁠⁠⁠⁠⁠⁠https://youtube.com/NewsmaxTV⁠⁠⁠⁠⁠⁠ -Rumble: ⁠⁠⁠⁠⁠⁠https://rumble.com/c/NewsmaxTV⁠⁠⁠⁠⁠⁠ -TRUTH Social: ⁠⁠⁠⁠⁠⁠https://truthsocial.com/@NEWSMAX⁠⁠⁠⁠⁠⁠ -GETTR: ⁠⁠⁠⁠⁠⁠https://gettr.com/user/newsmax⁠⁠⁠⁠⁠⁠ -Threads: ⁠⁠⁠⁠⁠⁠http://threads.net/@NEWSMAX⁠⁠⁠⁠⁠⁠  -Telegram: ⁠⁠⁠⁠⁠⁠http://t.me/newsmax⁠⁠⁠⁠⁠⁠  -BlueSky: ⁠⁠⁠⁠⁠⁠https://bsky.app/profile/newsmax.com⁠⁠⁠⁠⁠⁠ -Parler: ⁠⁠⁠⁠⁠⁠http://app.parler.com/newsmax⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Today I talk about the US military missions against alleged drug boats near Venezuela using Foucault's theory of knowledge/power. Support the show

You're listening to American Ground Radio with Stephen Parr and Louis R. Avallone. This is the full show for December 11, 2025. 0:30 Today we take a look at yet another glaring example of two-tier justice in America — after a federal grand jury in Virginia declined, for the second time, to indict New York Attorney General Letitia James on mortgage fraud allegations. We walk through how James built her entire political brand on accusing Donald Trump and his family of fraud, running explicitly on the promise to “get Trump.” But when she herself is accused of misrepresenting property information to secure financial benefits, the legal system suddenly hesitates. Standards soften. Intent becomes “unclear.” Evidence is “open to interpretation.” 9:30 Plus, we cover the Top 3 Things You Need to Know. The Bureau of Labor Statistics release a report this week saying that for the fifth straight month, increases in wages have outpaced inflation. The House of Representatives passed the Defense Authorization Act. The court fight over Illegal alien and alleged human trafficker Kilmar Abrego-Garcia continues. 12:30 Get Performlyte from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 13:00 Meta is now claiming its “enforcement mistakes” have dropped by 90% — a number the hosts say tells you everything you need to know about what was really happening before. After scrapping third-party fact checkers and the COVID-era censorship apparatus, Meta suddenly says it’s doing better. But were these simple “mistakes" or intentional acts of censorship, carried out under pressure from the Biden administration, where true information was labeled misinformation and users were silenced on purpose? Call it enforcement if you want — just don’t call it accidental. 15:30 American Mamas Teri Nettervile and Kimberly Burelson tackle a question that hits a cultural nerve: should a woman ever propose to a man — especially if he hasn’t done it himself? Using a viral video of a woman proposing after 14 years of dating as the jumping-off point, the conversation turns blunt, emotional, and unapologetically traditional. Their take is clear: if a man hasn’t proposed after years together, it’s not hesitation — it’s a decision. They argue that public proposals by women often flip natural dynamics, leaving the woman looking desperate and the man embarrassed, and point out that nearly every example online shows visible discomfort rather than romance. If you'd like to ask our American Mamas a question, go to our website, AmericanGroundRadio.com/mamas and click on the Ask the Mamas button. 22:30 AOC brands herself as the champion of the working class — railing against capitalism, wealth, and privilege — but new campaign spending tells a different story. Records show tens of thousands of donor dollars spent in Puerto Rico on luxury venues and high-end accommodations, all framed as “social justice.” 26:00 We break down the strategic showdown unfolding in the Caribbean — and it’s not an invasion, it’s pressure. Despite media speculation about war with Venezuela, Trump is doing the opposite of Iraq-style nation-building, opting instead for maximum force short of boots on the ground. From drug boats being seized and destroyed on the high seas to a sanctioned Venezuelan oil tanker taken by U.S. forces, this is a deliberate chokehold on Maduro’s funding streams. Drug trafficking, illegal oil shipments, shadow fleets — all of it bankrolls a corrupt regime propped up by repression and bribes. Cut the money, and the regime collapses from the inside. 32:00 Get Prodovite Plus from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 32:30 We revisit a once-dominant figure in late-night television and argue that David Letterman’s legacy has curdled with age. Wewalk through his cultural importance — the post-Carson era, the Letterman-Leno wars, and how an entire generation grew up on his humor — before contrasting that version of Letterman with the man who recently appeared on Jimmy Kimmel. 35:30 We zeroe in on Congresswoman Jasmine Crockett’s Senate run in Texas and what we see as a self-inflicted implosion. Wewith her on-air claim that Democrats don’t incite violence — daring anyone to find clips proving otherwise — and argue she dramatically underestimated how easy that challenge would be. Enter the RNC, which responds with a rapid-fire montage of prominent Democrats using explicitly violent rhetoric, from calls for unrest in the streets to threats of physical harm. It's a brutal receipts moment, made worse when the compilation turns back on Crockett herself, highlighting multiple clips of her talking about punching opponents, knocking people out, and “beating you down.” 39:30 Gavin Newsom released an AI-generated video depicting President Trump, Defense Secretary Pete Hegseth, and senior White House official Stephen Miller in handcuffs under the caption “It’s cuffing season.” This isn’t satire or clever political mockery — it’s outright disrespect from a sitting governor toward the commander in chief, with no explanation of what crime is supposedly being implied. And we're saying, "Whoa." See omnystudio.com/listener for privacy information.

This is the 69th episode in my drug pronunciation series. In this episode, I divide Kisunla and donanemab-azbt into syllables, tell you which syllables to emphasize, and share my sources. The written pronunciations are below and in the show notes on https://www.thepharmacistsvoice.com. Special thanks to Megan Hull, PharmD for inspiring me to pick Kisunla for this series. She mentioned it during the CE session she led at the Midyear Meeting of the Ohio Pharmacists Association in Nov 2025.   Note: we don't cover pharmacology in this series. Just pronunciations.   ⭐️Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF ⭐️   Kisunla = kih-SUHN-lah kih, like kiss SUHN, like sunshine lah, like lullaby Emphasize SUHN Written pronunciation source: Medication Guide for Kisunla on https://kisunla.lilly.com/ (accessed 12-10-25). Spoken pronunciation example: Patient testimonial video https://kisunla.lilly.com/patient-stories (accessed 12-10-25).   Donanemab-azbt = doe-NAN-e-mab A-Z-B-T doe, as in a female deer NAN, like the woman's name, Nancy e, which is a short "E" sound or a schwa "E" sound mab, which is the stem (or suffix) for a monoclonal antibody Emphasize NAN Written pronunciation sources: USP Dictionary Online and medlineplus.gov. (accessed 12-10-25)  Spoken pronunciation example by Ronald Petersen MD, PhD YouTube video on Mayo Clinic's YouTube Channel (accessed 12-10-25)   If you know someone who would like to learn how to say Kisunla and donanemab-azbt, please share this episode with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).    Other episodes in this series The Pharmacist's Voice Podcast Episode 358, Pronunciation Series Episode 68 (Journavx) The Pharmacist's Voice Podcast Episode 356, Pronunciation Series Episode 67 (Zanaflex) The Pharmacist's Voice Podcast Episode 352, Pronunciation Series Episode 66 (Yescarta) The Pharmacist's Voice Podcast Episode 350, Pronunciation Series Episode 65 (Xarelto) The Pharmacist's Voice Podcast Episode 349, Pronunciation Series Episode 64 (acetaminophen) The Pharmacist's Voice Podcast Episode 348, Pronunciation Series Episode 63 (Welchol/colesevelam) The Pharmacist's Voice Podcast Episode 346, Pronunciation Series Episode 62 (valacyclovir) The Pharmacist's Voice Podcast Episode 343, Pronunciation Series Episode 61 (ubrogepant) The Pharmacist's Voice Podcast Episode 341, Pronunciation Series Episode 60 (topiramate) The Pharmacist's Voice Podcast Episode 339, Pronunciation Series Episode 59 (Suboxone) The Pharmacist's Voice Podcast Episode 337, Pronunciation Series Episode 58 (rosuvastatin)  The Pharmacist's Voice Podcast Episode 335, Pronunciation Series Episode 57 (QVAR) The Pharmacist's Voice Podcast Episode 333, Pronunciation Series Episode 56 (pantoprazole)  The Pharmacist's Voice Podcast Episode 330, Pronunciation Series Episode 55 (oxcarbazepine) The Pharmacist's Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacist's Voice Podcast Episode 326, Pronunciation Series Episode 53 (Myrbetriq) The Pharmacist's Voice Podcast Episode 324, Pronunciation Series Episode 52 (liraglutide)  The Pharmacist's Voice Podcast Episode 322, Pronunciation Series Episode 51 (ketamine) The Pharmacist's Voice Podcast Episode 320, Pronunciation Series Episode 50 (Jantoven) The Pharmacist's Voice Podcast Episode 318, Pronunciation Series Episode 49 (ipratropium) The Pharmacist's Voice Podcast Episode 316, Pronunciation Series Episode 48 (hyoscyamine) The Pharmacist's Voice Podcast Episode 313, Pronunciation Series Episode 47 (guaifenesin) The Pharmacist's Voice Podcast Episode 311, Pronunciation Series Episode 46 (fluticasone) The Pharmacist's Voice Podcast Episode 309, Pronunciation Series Episode 45 (empagliflozin) The Pharmacist's Voice Podcast Episode 307, Pronunciation Series Episode 44 (dapagliflozin) The Pharmacist's Voice Podcast Episode 304, Pronunciation Series Episode 43 (cetirizine)  The Pharmacist's Voice Podcast Episode 302, Pronunciation Series Episode 42 (buspirone)  The Pharmacist's Voice Podcast Episode 301, Pronunciation Series Episode 41 (azithromycin) The Pharmacist's Voice Podcast Episode 298, Pronunciation Series Episode 40 (umeclidinium) The Pharmacist's Voice Podcast Episode 296, Pronunciation Series Episode 39 (Januvia)  The Pharmacist's Voice Podcast Episode 294, Pronunciation Series Episode 38 (Yasmin) The Pharmacist's Voice Podcast Episode 292, Pronunciation Series Episode 37 (Xanax, alprazolam) The Pharmacist's Voice Podcast Episode 290, Pronunciation Series Episode 36 (quetiapine)  The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin)  The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine)  The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec)  The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol)  The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC)  The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide)  The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta   Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com  ✅ Podcasting course https://www.kimnewlove.com/podcasting  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with my coach, Dave Jackson from The School of Podcasting! *New 12-4-25* Click my affiliate link: https://community.schoolofpodcasting.com/invitation?code=G43D3G    Thank you for listening to episode 360 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

https://www.youtube.com/watch?v=aBSu1A2_BSg Podcast audio: In this episode of the Ayn Rand Institute podcast, Ben Bayer and Elan Journo discuss the recent American attacks on alleged drug boats in the Caribbean and scrutinize pretexts for war with Venezuela. Topics include:  “War crimes” and international law; The fake “terrorist” threat; The “war on drugs”;  The Venezuelan military “threat”; Authoritarian presidential power. Resources:  Ayn Rand, “The Roots of War” This episode was recorded on December 9, 2025, and posted on December 11, 2025. Listen and subscribe wherever you get your podcasts. Watch archived podcasts here. Image Credits: Venezuela flag: Kryssia Campos / Moment / via Getty Images; Trump: Chip Somodevilla / via Getty Images

This episode features a large news slate: Federal Reserve's latest interest rate cut, Jobless claims rise the most since early 2020 and New study raises hopes for Lilly's next obesity drug. Roundtable: Tips for beginniers / QOFTWhttps://www.instagram.com/delano.saporu/?hl=en. Connect with me here also: https://newstreetadvisorsgroup.com/social/. Want to support the show? Feel free to do so here! https://anchor.fm/delano-saporu4/support. Thank you for listening.

Max Blumenthal : DEA Drug Gangsters; Netanyahu's Fears.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The teenage years are a crucial time to prevent addiction. The brain is still developing, making it more vulnerable to the lasting effects of drugs and alcohol. It's also a time when peer pressure can lead to risky choices. So how do you help teens not only say no, but also inspire their friends and communities to make better decisions?In this episode of Grieving Out Loud, meet Annabelle Lovell, a high school junior raising awareness about the dangers of teen drug and alcohol use—not just at her school, but across the country. She recently served as the opening speaker at CADCA's national conference. CADCA, or Community Anti-Drug Coalitions of America, represents thousands of community coalitions nationwide, making Annabelle's role a major honor and responsibility for someone her age.Annabelle joins us along with Mollie Kruse, a member of our Emily's Hope Youth Prevention Coalition, who's taken the message all the way to Washington, D.C., even meeting with the Senate majority leader to talk about the importance of preventing substance use. Together, they share their advice for parents, educators, and other teens as the nation continues to face a deadly drug epidemic.If you enjoyed this episode, you may like the following: Why So Many Teens are Struggling, and What We're MissingGrowing Up with Grief: Emily's Siblings Open UpInside Victoria's Voice: The Diary That's Waking Parents UpSend us a textBehind every number is a story of a life cut short, a family shattered, and a community devastated.They were...daughterssonsmothersfathersfriendswiveshusbandscousinsboyfriendsgirlfriends.They were More Than Just A Number. Support the showConnect with Angela Follow Grieving Out Loud Follow Emily's Hope Read Angela's Blog Subscribe to Grieving Out Loud/Emily's Hope Updates Suggest a Guest For more episodes and information, just go to our website, emilyshope.charityWishing you faith, hope and courage!Podcast producers:Casey Wonnenberg King & Kayli Fitz

Angel Studios https://Angel.com/Herman Join the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeEpisode Links:A video by Gates Garcia - A message to Nick Fuentes followersGreat stuff from @NickJFreitas on understanding and reaching young men. The church needs to get this.A first of its kind government lawsuit has been launched against 11 Big Food companies for knowingly creating highly addictive, poisonous, ultra processed foodsThis is what the streets of San Francisco California look like. American asks the workers if it's hard to clean up, they respond they have to clean this up every single day. Every day it's trashed again. Drug zombies are seen everywhere unable to stand as he walks around (insane)Some days before I get outside in San Francisco, this is how the Ring camera looks like.The first time I saw zombies in Ring camera, I thought there must be some special immersive theater event happening. Now I know it's just a part of life.Japan really said ‘self-care, but make it sci-fi'. A machine that washes humans in 15 minutes… at this point my washing machine is jealous.What Does God's Word Say?1 Timothy 4:12Let no one despise you for your youth, but set the believers an example in speech, in conduct, in love, in faith, in purity.Ecclesiastes 11:9  Rejoice, O young man, in your youth, and let your heart cheer you in the days of your youth. Walk in the ways of your heart and the sight of your eyes. But know that for all these things God will bring you into judgment.Psalm 119:9  How can a young man keep his way pure? By guarding it according to your word.2 Timothy 2:22  So flee youthful passions and pursue righteousness, faith, love, and peace, along with those who call on the Lord from a pure heart.Romans 12:2 NIVDo not conform to the pattern of this world, but be transformed by the renewing of your mind. Then you will be able to test and approve what God's will is – his good, pleasing and perfect will.Philippians 4:8 NIVFinally, brothers and sisters, whatever is true, whatever is noble, whatever is right, whatever is pure, whatever is lovely, whatever is admirable–if anything is excellent or praiseworthy–think about such things.Ephesians 4:22-24 NIVYou were taught, with regard to your former way of life, to put off your old self, which is being corrupted by its deceitful desires; to be made new in the attitude of your minds; and to put on the new self, created to be like God in true righteousness and holiness.2 Corinthians 10:5 NIV We demolish arguments and every pretension that sets itself up against the knowledge of God, and we take captive every thought to make it obedient to Christ.

-Rob barrels into Hour 2 by declaring Somalia the “Independence Day alien species of nations,” while insisting Democrats act like a worldwide fraud network is just a cultural exchange program. -Thane Rosenbaum joins via the Newsmax Hotline, brilliantly roasting the absurdity of treating terrorists, cartels, and fentanyl boats like protected wildlife. Today's podcast is sponsored by : BEAM DREAM POWDER - Refreshing sleep now 40% off with promo code NEWSMAX at http://shopbeam.com/newsmax BIRCH GOLD - Protect and grow your retirement savings with gold. Text ROB to 98 98 98 for your FREE information kit!WEBROOT : Live a better digital life with Webroot Total Protection. Rob Carson Show listeners get 60% off at http://webroot.com/Newsmax  To call in and speak with Rob Carson live on the show, dial 1-800-922-6680 between the hours of 12 Noon and 3:00 pm Eastern Time Monday through Friday…E-mail Rob Carson at : RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (http://patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media:  -Facebook: http://nws.mx/FB  -X/Twitter: http://nws.mx/twitter -Instagram: http://nws.mx/IG -YouTube: https://youtube.com/NewsmaxTV -Rumble: https://rumble.com/c/NewsmaxTV -TRUTH Social: https://truthsocial.com/@NEWSMAX -GETTR: https://gettr.com/user/newsmax -Threads: http://threads.net/@NEWSMAX  -Telegram: http://t.me/newsmax  -BlueSky: https://bsky.app/profile/newsmax.com -Parler: http://app.parler.com/newsmax Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we look at a series of recent arrests tied to online posts, comparing Britain's policing culture and firearms laws with American norms and examining how “feeling threatened” has become a legal standard. We discuss Alaska's new AI-driven digital identity system and the fears surrounding automated benefits, digital currency, and government control. We highlight the week's “foolishness” involving a racist outburst at a Cinnabon, and then turn to market news as Bitcoin drops and DJT stock continues to collapse. Our main topic explores whether AI can ever be sentient, what genuine inquisitiveness looks like, how people project humanity onto algorithms, and why the real risks stem from human psychology rather than runaway machines. We close with a discussion of how AI affects relationships, personal responsibility, and why students shouldn't rely on it to think for them. 00:00 Introduction and Overview 01:01 British Man Arrested Over Social Media Post 02:46 Police Overreach and “Feelings as Law” 05:14 Global Jurisdiction and Ridiculous Laws 06:51 Alaska's AI-Driven Digital Identity System 07:35 AI Applying for Benefits on Your Behalf 09:17 Digital Currency and Government Control Fears 12:11 Foolishness of the Week: The Cinnabon Racism Incident 13:22 Why Do Racists Get GoFundMes? 14:30 Bitcoin's Drop and the DJT Stock Collapse 19:36 Can AI Become Sentient? 22:05 The Inquisitiveness Test for Consciousness 26:31 Will AI Replace Human Relationships? 30:30 What Long-Term Interaction Reveals About AI 36:46 Asking AI About Sentience 40:00 Real Risks: Errors, Psychology, and Human Behavior 43:15 AI as a Mirror of Human Behavior 45:02 Practical and Realistic Uses of AI 50:18 Why Students Shouldn't Rely on AI for Schoolwork 53:40 Drug-fueled Observations on Human Behavior Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week, Danielle and Kristine learn how to survive exposure to sulfuric acid — trust us, you don't want to mess around with this chemical. Then Jeremy Bent joins to share the unfortunate way he discovered he's allergic to sulfa-based antibiotics.

-Rob is gleefully cheering on exploding narco-boats while accusing Democrats of defending drug cartels simply to oppose Trump. -A deep dive into alleged Minnesota/Somali fraud sends Rob into full turbo mode, complete with parody Christmas songs and vows of bureaucratic colonoscopies. Today's podcast is sponsored by : BEAM DREAM POWDER - Refreshing sleep now 40% off with promo code NEWSMAX at http://shopbeam.com/newsmax BIRCH GOLD - Protect and grow your retirement savings with gold. Text ROB to 98 98 98 for your FREE information kit!WEBROOT : Live a better digital life with Webroot Total Protection. Rob Carson Show listeners get 60% off at http://webroot.com/Newsmax  To call in and speak with Rob Carson live on the show, dial 1-800-922-6680 between the hours of 12 Noon and 3:00 pm Eastern Time Monday through Friday…E-mail Rob Carson at : RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (http://patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media:  -Facebook: http://nws.mx/FB  -X/Twitter: http://nws.mx/twitter -Instagram: http://nws.mx/IG -YouTube: https://youtube.com/NewsmaxTV -Rumble: https://rumble.com/c/NewsmaxTV -TRUTH Social: https://truthsocial.com/@NEWSMAX -GETTR: https://gettr.com/user/newsmax -Threads: http://threads.net/@NEWSMAX  -Telegram: http://t.me/newsmax  -BlueSky: https://bsky.app/profile/newsmax.com -Parler: http://app.parler.com/newsmax Learn more about your ad choices. Visit megaphone.fm/adchoices

Dave Rubin of "The Rubin Report" talks to Winston Marshall and Sean Spicer about CNN's Abby Phillip getting uncomfortable as Batya Ungar-Sargon calmly debunks the entire "war Crimes" narrative concerning Pete Hegseth's orders regarding a second strike on a Venezuelan drug boat with a series of facts that Democrats would like to continue to ignore; Jesse Watters and Stephen Miller getting a huge laugh as ABC News' host of "This Week" Martha Raddatz reveals new details of the drug boat strike that backs up Pete Hegseth and the Trump administration's version of events; a resurfaced clip of Joe Biden from 1989 that is going viral where he pushed for more aggressive tactics to fight narco terrorists in the war on drugs; Chicago Mayor Brandon Johnson's pathetic response to getting grilled about his lack of concern of the shocking amount of teenage shootings occurring in the downtown Chicago area; Donald Trump's brutally honest response to being told that Minneapolis Mayor Jacob Frey is proud of the Minnesota Somali community after allegations of massive fraud against the state;a CNN host by New Orleans City Councilwoman Lesli Harris refusing to accept any help from ICE to handle violent criminals who target minors; and much more. WATCH the MEMBER-EXCLUSIVE segment of the show here: https://rubinreport.locals.com/ Check out the NEW RUBIN REPORT MERCH here: https://daverubin.store/ ---------- Today's Sponsors: Rumble Premium - Corporate America is fighting to remove speech, Rumble is fighting to keep it. If you really believe in this fight Rumble is offering $10 off with the promo code RUBIN when you purchase an annual subscription. Go to: https://Rumble.com/premium/RUBIN and use promo code RUBIN